Journal ArticleDOI
The Added Role of MR Imaging in Treatment Stratification of Patients with Gynecologic Malignancies: What the Radiologist Needs to Know
TLDR
The purpose of this review is to highlight the added role of MR imaging in the treatment stratification and overall care of patients with endometrial, cervical, or ovarian cancer.Abstract:
Advances in MR imaging techniques, along with the growing role of the radiologist as part of a multidisciplinary treatment-planning team, have become central in tailoring treatment options and frequently lead to modifications in the therapeutic approach in patients with gynecologic malignancies.read more
Citations
More filters
Journal ArticleDOI
MR Imaging-Pathologic Correlation in Ovarian Cancer.
Erica B. Stein,Erica B. Stein,Ashish P. Wasnik,Andrew P. Sciallis,Aya Kamaya,Katherine E. Maturen +5 more
TL;DR: There are many ovarian cancer subtypes, giving rise to a range of appearances at gross pathology and magnetic resonance (MR) imaging, which contribute substantially to clinical decision making and patient management.
Journal ArticleDOI
Utility of diffusion-weighted and contrast-enhanced magnetic resonance imaging in diagnosing and differentiating between high- and low-grade uterine endometrial stromal sarcoma.
Yen-Ling Huang,Yen-Ling Huang,Shir-Hwa Ueng,Kueian Chen,Kueian Chen,Yu-Ting Huang,Hsin-Ying Lu,Hsin-Ying Lu,Koon-Kwan Ng,Ting-Chang Chang,Chyong-Huey Lai,Gigin Lin,Gigin Lin +12 more
TL;DR: Diffusion-weighted MR imaging is useful in diagnosing ESS against T2-hyperintense leiomyomas, and contrast enhancement aids in further differentiating between high- and low-grade ESS.
Journal ArticleDOI
The added value of diffusion-weighted imaging in the preoperative assessment of endometrial cancer.
TL;DR: The addition of DWI apparently improves the diagnostic accuracy of MRI in the preoperative assessment of the depth of myometrial invasion in endometrial cancer, which may be particularly helpful in patients for whom contrast agents are contraindicated.
Journal ArticleDOI
ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer
Expert Panel on Gyn,OB Imaging,Caroline Reinhold,Yoshiko Ueno,Esma A Akin,Priyadarshani R. Bhosale,Kika M. Dudiak,Anuja Jhingran,Stella K. Kang,Aoife Kilcoyne,Yulia Lakhman,Refky Nicola,Pari V. Pandharipande,Rajmohan Paspulati,Atul B. Shinagare,William Small,Hebert Alberto Vargas,Bradford P. Whitcomb,Phyllis Glanc +18 more
TL;DR: The role of pelvic imaging in assessing local disease extent during initial staging in patients with endometrial carcinoma is little consensus, but when pretreatment assessment of local tumor extent is indicated, MRI is the preferred imaging modality.
Journal ArticleDOI
Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence.
Shinya Matsuzaki,Maximilian Klar,Mikio Mikami,Muneaki Shimada,Brendan H. Grubbs,Keiichi Fujiwara,Lynda D. Roman,Koji Matsuo +7 more
TL;DR: Based on the results of recent level I evidence, the standard treatment for stage IIB cervical cancer remains CCRT.
References
More filters
Journal ArticleDOI
Cancer statistics, 2010
TL;DR: The American Cancer Society as mentioned in this paper estimated the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data regarding cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from National Center for Health Statistics.
National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology
DG Pfister,K. K. Ang,D Brizel +2 more
Journal ArticleDOI
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote,Claes G. Tropé,Frédéric Amant,G.B. Kristensen,Tom Ehlen,N Johnson,René H.M. Verheijen,Maria E. L. van der Burg,A. J. Lacave,Pierluigi Benedetti Panici,Gemma G. Kenter,Antonio Casado,Cesar Mendiola,Corneel Coens,Leen Verleye,Gavin Stuart,Sergio Pecorelli,Nicholas Reed +17 more
TL;DR: Neoadjuvant chemotherapy followed by interval debulking surgery was not inferior to primary debulked surgery followed by chemotherapy as a treatment option for patients with bulky stage IIIC or IV ovarian carcinoma in this study.
Journal ArticleDOI
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
Anwar R. Padhani,Guoying Liu,Dow Mu-Koh,Thomas L. Chenevert,Harriet C. Thoeny,Taro Takahara,Andrew Dzik-Jurasz,Brian D. Ross,Marc Van Cauteren,David J. Collins,Dima A. Hammoud,Gordon J. S. Rustin,Bachir Taouli,Peter L. Choyke +13 more
TL;DR: DW-MRI should be tested as an imaging biomarker in the context of well-defined clinical trials, by adding DW-MRI to existing NCI-sponsored trials, particularly those with tissue sampling or survival indicators, and standards for measurement, analysis, and display are needed.